The University of Alabama at Birmingham (UAB) Rheumatic Disease Core Center (RDCC) is amultidisciplinary program designed to foster and promote the application of scientifically rigorous, state of theart techniques to important questions in biomedical research in order to advance our basic understanding ofdisease and, thereby, improve the diagnosis and treatment of patients with arthritis and musculoskeletaldiseases. The Administrative Core is specifically designed to coordinate RDCC activities while facilitatingnteractions and collaborations, promoting scientific development, setting the strategic agenda, andperforming continuous evaluation of ongoing programs. The Administrative Unit will enable optimalcoordination of the various components through its committees and regularly scheduled meetings andseminars serving to enhance communication and scientific development among the various investigators.Three committees have been established to ensure the highest quality in the operation of the RDCC: theExecutive Committee, made up of the Center Director (Carter), the Associate Director (Mountz), and thedirector of each core (Accavitti, Kesterson, Keyser and Carter); the Internal Advisory Committee, chaired bythe Director of the UAB Arthritis and Musculoskeletal Center (Kimberly); and the External AdvisoryCommittee (Fox, Holers, and Ivashkiv). These advisory groups will counsel and assist the Center Director inmaximizing the strengths of the RDCC cores, Pilot and Feasibility projects, and Scientific EnrichmentProgram and with strategic planning in each of the thematic areas of the RDCC. The Executive Committeewill also be a forum for feedback from the advisory committees established for each core. The CenterDirector will be responsible for operations, communication, and overall leadership. The Associate Director will have primary responsibility for oversight of the P&F projects. The personnel of the Administrative Core are highly motivated and experienced and will assist the Director, Associate Director and the three committees by ensuring efficient communications, logistical support and fiscal responsibility in the operation of the RDCC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR048311-06
Application #
7352453
Study Section
Special Emphasis Panel (ZAR1-KM-K (M1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
6
Fiscal Year
2007
Total Cost
$110,200
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Yang, Zhengrong; Hildebrandt, Ellen; Jiang, Fan et al. (2018) Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1. Biochim Biophys Acta Biomembr 1860:1193-1204
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Chen, Wei; Zhu, Guochun; Jules, Joel et al. (2018) Monocyte-Specific Knockout of C/ebp? Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebp? in Osteoclast Differentiation and Function. J Bone Miner Res 33:691-703
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Jo, SeongHo; Chen, Junqin; Xu, Guanlan et al. (2018) miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 67:256-264
Stafman, Laura L; Williams, Adele P; Garner, Evan F et al. (2018) Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Transl Oncol 12:200-208
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618

Showing the most recent 10 out of 340 publications